PARIS (Reuters) - U.S. cancer drug company Medivation Inc set June 1 as the date to determine which of its shareholders are eligible to take part in giving written consent to remove and replace its board of directors,gemini vs cancer fight who would win after French drugmaker Sanofi submitted a notice.

Sanofi named eight candidates to replace the entire board of Medivation last week, stepping up pressure on the U.S. cancer drug company which has rejected the French company's $9.3 billion takeover approach.

Sanofi said in a statement on Wednesday that the latest day the Medivation board can set the deadline, or the record date, is June 22.

After the record date, Medivation directors can be removed and replaced if shareholders of a majority of the outstanding shares agree to the proposal, it added.

(Reporting by Matthias Blamont, Dominique Vidalon; Additional reporting by Shalini Nagarajan in Bengaluru; Editing by Susan Fenton and Sandra Maler)

View comments

• ·Dorian LPG: Q2 Earnings Insights
• ·Zacks Rank #5 Additions for Monday
• ·Intrinsic Calculation For Old Dominion Freight Line, Inc. (NASDAQ:ODFL) Shows Investors Are Overpaying
• ·Should You Like u-blox Holding AG’s (VTX:UBXN) High Return On Capital Employed?
• ·Apple's New Deal With Amazon Prime Video Is a Game Changer
• ·Sony Announces the α77II (Alpha 77 Mark II) Translucent Mirror DSLR Camera
• ·B+S Banksysteme Aktiengesellschaft (FRA:DTD2) Has A ROE Of 8.1%
• ·Whitney Houston's death: Wendy Williams breaks down -- VIDEO
• ·Unusual Options Activity Insight: Plug Power
• ·Kellie Pickler shaves her head: PHOTO
• ·What Should You Know About The Future Of AstraZeneca PLC’s (LON:AZN)?
• ·Why the Earnings Surprise Streak Could Continue for Stryker (SYK)
• ·Great Ajax Corp. to Host Earnings Call
• ·7 of the best laptop brands of 2019
• ·NY Lawmakers Move Closer to Approving Criminal Justice Reform Legislation
• ·The top iPhone and iPad apps on App Store